Opendata, web and dolomites

PROOF SIGNED

Penumbral Rescue by Normobaric O=O Administration in Patients With Ischaemic Stroke and Target Mismatch ProFile: A Phase II Proof-of-Concept Trial

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 PROOF project word cloud

Explore the words cloud of the PROOF project. It provides you a very rough idea of what is the project "PROOF" about.

initiated    hours    primarily    morbidity    attenuated    care    minutes    rebreather    ease    hypoxia    fio2    gt    24    disruption    world    arteries    proximal    endpoints    core    circulation    worldwide    supply    administered    35    100    sustaining    nbho    hyperoxygenation    penumbra    center    oelig    vessel    economics    proves    injury    surrounding    seems    bridging    neuronal    anterior    criterion    proof    penumbral    occlusion    therapeutic    oxygen    stroke    impacts    volume    min    hypoperfused    ventilation    patients    logical    ischaemia    mask    considering    until    secondary    mortality    outcomes    probe    intubation    flow    salvageable    ischemic    societal    iib    efficacy    onset    permil    reperfusion    undertaken    day    caused    blood    24h    mediated    cell    tissue    45    shift    blinded    infarct    randomized    leads    standard    infarction    population    rankin    reduces    time       neuroprotective    trials    animal    transient    death    window    risk    endpoint    treatment    significantly    models    qol    nihss    primary    50    accessible    baseline    modified    health    acirc    curren    treatments    categorical    label    score    surrogate    recanalization    widen    brain    adaptive    biomarkers    normobaric    pressure    cognition   

Project "PROOF" data sheet

The following table provides information about the project.

Coordinator
EBERHARD KARLS UNIVERSITAET TUEBINGEN 

Organization address
address: GESCHWISTER-SCHOLL-PLATZ
city: TUEBINGEN
postcode: 72074
website: www.uni-tuebingen.de

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Germany [DE]
 Project website http://www.proof-trial.eu
 Total cost 5˙997˙347 €
 EC max contribution 5˙778˙827 € (96%)
 Programme 1. H2020-EU.3.1.3. (Treating and managing disease)
 Code Call H2020-SC1-2016-RTD
 Funding Scheme RIA
 Starting year 2017
 Duration (year-month-day) from 2017-01-01   to  2021-12-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    EBERHARD KARLS UNIVERSITAET TUEBINGEN DE (TUEBINGEN) coordinator 1˙498˙742.00
2    UNIVERSITATSKLINIKUM HEIDELBERG DE (HEIDELBERG) participant 1˙350˙776.00
3    EPPDATA GMBH DE (HAMBURG) participant 737˙875.00
4    FUNDACIO HOSPITAL UNIVERSITARI VALL D'HEBRON - INSTITUT DE RECERCA ES (BARCELONA) participant 679˙923.00
5    ECRIN EUROPEAN CLINICAL RESEARCH INFRASTRUCTURE NETWORK FR (PARIS) participant 434˙733.00
6    KATHOLIEKE UNIVERSITEIT LEUVEN BE (LEUVEN) participant 321˙625.00
7    CENTRE HOSPITALIER SAINTE ANNE DE PARIS FR (PARIS CEDEX 14) participant 246˙814.00
8    VASTRA GOTALANDS LANS LANDSTING SE (VANERSBORG) participant 185˙600.00
9    HELSINGIN JA UUDENMAAN SAIRAANHOITOPIIRIN KUNTAYHTYMÄ FI (HELSINKI) participant 137˙463.00
10    FAKULTNI NEMOCNICE U SV. ANNY V BRNE CZ (Brno) participant 118˙650.00
11    STROKE ALLIANCE FOR EUROPE BE (BRUSSELS) participant 66˙625.00
12    CENTRE HOSPITALIER UNIVERSITAIRE VAUDOIS CH (LAUSANNE) participant 0.00

Map

 Project objective

Ischemic stroke (IS), caused by occlusion of arteries that supply blood to the brain, remains a leading cause of mortality and morbidity in the world. Disruption of blood and oxygen supply to the brain leads to neuronal death in the ischemic core within minutes. The hypoperfused tissue surrounding the ischemic core, the penumbra, is at high risk for infarction over time but still salvageable. Neuroprotective “bridgingâ€Â, sustaining the penumbra until reperfusion, may widen the therapeutic window, make recanalization treatments accessible to more patients and improve overall IS outcomes. As ischemic cell death is primarily mediated by hypoxia, increasing oxygen supply to the penumbra seems THE logical approach. In animal models of IS, normobaric hyperoxygenation (NBHO) significantly increased penumbral oxygen pressure and attenuated brain injury when initiated early after onset of ischaemia and vessel occlusion was transient (35 to 50% infarct volume reduction). The PROOF project now seeks to demonstrate that NBHO (high-flow 100% oxygen at >45 L/min via a non-rebreather mask, or FiO2=1.0 for intubation/ventilation) reduces infarct growth from baseline to 24 hours compared to standard treatment if administered ≤3 hours after onset of anterior circulation IS, in patients with proximal vessel occlusion and salvageable tissue at risk. The study is multi-center, adaptive phase-IIb, randomized, open-label with blinded-endpoint (PROBE design). The primary efficacy criterion will be infarct growth from baseline to 24 hours. Secondary endpoints will be NIHSS 24h, categorical shift in the pre-stroke modified Rankin Score, QoL and cognition at day 90. Potential surrogate biomarkers, health economics and societal impacts will be assessed. If NBHO proves its neuroprotective potential in this selected population, phase-III trials in all IS patients may be undertaken. Considering its low costs and ease of use, NBHO may impact stroke care worldwide.

 Deliverables

List of deliverables.
PROOF communication and dissemination tools Documents, reports 2020-01-27 12:40:00
Final list of participating centres Documents, reports 2020-01-27 12:40:00
DSMB Formation Other 2020-01-27 12:40:00

Take a look to the deliverables list in detail:  detailed list of PROOF deliverables.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "PROOF" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "PROOF" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.3.)

ISLET (2020)

Advancing Innovative Stem Cell-based Therapy for Diabetes in Europe

Read More  

GACD (2019)

Global Alliance for Chronic Diseases Secretariat

Read More  

VANGUARD (2020)

New Generation Cell Therapy: Bioartificial Pancreas to Cure Type 1 Diabetes

Read More